The leading company pioneering artificial intelligence (AI)-fueled drug discovery could get much bigger. In a nutshell, these businesses are trying to convince big pharma that their AI technology can ...
Recursion Pharmaceuticals is merging with Exscientia. The new entity will have the backing of quite a few big names in pharma. It'll also have an even more capable drug discovery and development ...
Recursion Pharmaceuticals (RXRX) shares soared 5.8% in the last trading session to close at $5.84. The move was backed by solid volume with far more shares changing hands than in a normal session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results